Skip to main content
SpringerLink
Log in
Book cover

Pharmacotherapy in Aortic Disease pp 1–64Cite as

Aortic Atherosclerosis as an Embolic Source

  • Chapter
  • First Online:

  • 872 Accesses

Part of the book series: Current Cardiovascular Therapy ((CCT,volume 7))

Abstract

Stroke is the third leading cause of death in several industrial countries and cardiogenic embolism accounts for 15–30 % of ischaemic strokes [1–5]. The diagnosis of a cardioembolic source of stroke is frequently uncertain and relies on the identification of a potential cardiac source of embolism in the absence of significant autochthonous cerebrovascular occlusive disease. In this regard, echocardiography (either transthoracic – TTE or Transoesophageal – TEE) serves as a cornerstone in the evaluation and diagnosis of these patients [6, 7].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ferro JM. Cardioembolic stroke: an update. Lancet Neurol. 2003;2(3):177–88. doi:S1474442203003247 [pii].

    PubMed  Google Scholar 

  2. Brickner ME. Cardioembolic stroke. Am J Med. 1996;100(4):465–74. doi:S0002934397895253 [pii].

    CAS  PubMed  Google Scholar 

  3. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(6):1583–633. doi:10.1161/01.STR.0000223048.70103.F1. 01.STR.0000223048.70103.F1 [pii].

    PubMed  Google Scholar 

  4. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(2):577–617. doi:10.1161/01.STR.0000199147.30016.74. 37/2/577 [pii].

    PubMed  Google Scholar 

  5. Adams Jr HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655–711. doi:10.1161/STROKEAHA.107.181486. STROKEAHA.107.181486 [pii].

    PubMed  Google Scholar 

  6. Flachskampf FA, Badano L, Daniel WG, Feneck RO, Fox KF, Fraser AG, Pasquet A, Pepi M, Perez de Isla L, Zamorano JL, Roelandt JR, Pierard L. Recommendations for transoesophageal echocardiography: update 2010. Eur J Echocardiogr. 2010;11(7):557–76. doi:10.1093/ejechocard/jeq057. jeq057 [pii].

    CAS  PubMed  Google Scholar 

  7. Pepi M, Evangelista A, Nihoyannopoulos P, Flachskampf FA, Athanassopoulos G, Colonna P, Habib G, Ringelstein EB, Sicari R, Zamorano JL, Sitges M, Caso P. Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2010;11(6):461–76. doi:10.1093/ejechocard/jeq045. jeq045 [pii].

    PubMed  Google Scholar 

  8. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey Jr DE, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol. 2010;55(14):e27–129. doi:10.1016/j.jacc.2010.02.015.

    PubMed  Google Scholar 

  9. Golledge J, Norman PE. Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? Arterioscler Thromb Vasc Biol. 2010;30(6):1075–7. doi:10.1161/ATVBAHA.110.206573. 30/6/1075 [pii].

    CAS  PubMed Central  PubMed  Google Scholar 

  10. Kronzon I, Saric M. Cholesterol embolization syndrome. Circulation. 2010;122(6):631–41. doi:10.1161/CIRCULATIONAHA.109.886465. 122/6/631 [pii].

    PubMed  Google Scholar 

  11. Saric M, Kronzon I. Cholesterol embolization syndrome. Curr Opin Cardiol. 2011;26(6):472–9. doi:10.1097/HCO.0b013e32834b7fdd. 00001573-201111000-00003 [pii].

    PubMed  Google Scholar 

  12. Tunick PA, Kronzon I. Atheromas of the thoracic aorta: clinical and therapeutic update. J Am Coll Cardiol. 2000;35(3):545–54.

    CAS  PubMed  Google Scholar 

  13. Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I. High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol. 1994;23(5):1085–90.

    CAS  PubMed  Google Scholar 

  14. Stern A, Tunick PA, Culliford AT, Lachmann J, Baumann FG, Kanchuger MS, Marschall K, Shah A, Grossi E, Kronzon I. Protruding aortic arch atheromas: risk of stroke during heart surgery with and without aortic arch endarterectomy. Am Heart J. 1999;138(4 Pt 1):746–52.

    CAS  PubMed  Google Scholar 

  15. Feder W, Auerbach R. “Purple toes”: an uncommon sequela of oral coumarin drug therapy. Ann Intern Med. 1961;55:911–7.

    CAS  PubMed  Google Scholar 

  16. Rosansky SJ, Deschamps EG. Multiple cholesterol emboli syndrome after angiography. Am J Med Sci. 1984;288(1):45–8.

    CAS  PubMed  Google Scholar 

  17. Hendel RC, Cuenoud HF, Giansiracusa DF, Alpert JS. Multiple cholesterol emboli syndrome. Bowel infarction after retrograde angiography. Arch Intern Med. 1989;149(10):2371–4.

    CAS  PubMed  Google Scholar 

  18. Ramirez G, O’Neill Jr WM, Lambert R, Bloomer HA. Cholesterol embolization: a complication of angiography. Arch Intern Med. 1978;138(9):1430–2.

    CAS  PubMed  Google Scholar 

  19. Wiseth R, Hallan H, Hatlinghus S, Bjerkeset T, Helseth A. Cholesterol embolization. A serious complication to angiography. Tidsskr Nor Laegeforen. 1988;108(28):2374–6.

    CAS  PubMed  Google Scholar 

  20. Drost H, Buis B, Haan D, Hillers JA. Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases. Br Heart J. 1984;52(3):339–42.

    CAS  PubMed Central  PubMed  Google Scholar 

  21. Hyman BT, Landas SK, Ashman RF, Schelper RL, Robinson RA. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med. 1987;82(6):1233–7.

    CAS  PubMed  Google Scholar 

  22. Shapiro LS. Cholesterol embolization after treatment with tissue plasminogen activator. N Engl J Med. 1989;321(18):1270. doi:10.1056/NEJM198911023211816.

    CAS  PubMed  Google Scholar 

  23. Bols A, Nevelsteen A, Verhaeghe R. Atheromatous embolization precipitated by oral anticoagulants. Int Angiol. 1994;13(3):271–4.

    CAS  PubMed  Google Scholar 

  24. Scolari F, Bracchi M, Valzorio B, Movilli E, Costantino E, Savoldi S, Zorat S, Bonardelli S, Tardanico R, Maiorca R. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant. 1996;11(8):1607–12.

    CAS  PubMed  Google Scholar 

  25. Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol. 1998;31(1):134–8. doi:S0735-1097(97)00449-X [pii].

    CAS  PubMed  Google Scholar 

  26. Davila-Roman VG, Kouchoukos NT, Schechtman KB, Barzilai B. Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg. 1999;117(1):111–6. doi:S0022522399000604 [pii].

    CAS  PubMed  Google Scholar 

  27. Gutsche JT, Cheung AT, McGarvey ML, Moser WG, Szeto W, Carpenter JP, Fairman RM, Pochettino A, Bavaria JE. Risk factors for perioperative stroke after thoracic endovascular aortic repair. Ann Thorac Surg. 2007;84(4):1195–200; discussion 1200. doi:10.1016/j.athoracsur.2007.04.128. S0003-4975(07)01087-9 [pii].

  28. Rodes-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bedard F, Doyle D, De Larochelliere R, Jayasuria C, Villeneuve J, Marrero A, Cote M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57(1):18–28. doi:10.1016/j.jacc.2010.07.036. S0735-1097(10)04224-5 [pii].

    PubMed  Google Scholar 

  29. Szeto WY, Augoustides JG, Desai ND, Moeller P, McGarvey ML, Walsh E, Bannan A, Herrmann HC, Bavaria JE. Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. J Card Surg. 2011;26(4):348–54. doi:10.1111/j.1540-8191.2011.01265.x.

    PubMed  Google Scholar 

  30. Blankenship JC, Butler M, Garbes A. Prospective assessment of cholesterol embolization in patients with acute myocardial infarction treated with thrombolytic vs conservative therapy. Chest. 1995;107(3):662–8.

    CAS  PubMed  Google Scholar 

  31. Davila-Roman VG, Barzilai B, Wareing TH, Murphy SF, Schechtman KB, Kouchoukos NT. Atherosclerosis of the ascending aorta. Prevalence and role as an independent predictor of cerebrovascular events in cardiac patients. Stroke. 1994;25(10):2010–6.

    CAS  PubMed  Google Scholar 

  32. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, Chauvel C, Touboul PJ, Bousser MG. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994;331(22):1474–9. doi:10.1056/NEJM199412013312202.

    CAS  PubMed  Google Scholar 

  33. Jones EF, Kalman JM, Calafiore P, Tonkin AM, Donnan GA. Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke. 1995;26(2):218–24.

    CAS  PubMed  Google Scholar 

  34. Nihoyannopoulos P, Joshi J, Athanasopoulos G, Oakley CM. Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol. 1993;71(13):1208–12.

    CAS  PubMed  Google Scholar 

  35. Stone DH, Brewster DC, Kwolek CJ, Lamuraglia GM, Conrad MF, Chung TK, Cambria RP. Stent-graft versus open-surgical repair of the thoracic aorta: mid-term results. J Vasc Surg. 2006;44(6):1188–97. doi:10.1016/j.jvs.2006.08.005.

    PubMed  Google Scholar 

  36. Di Tullio MR, Sacco RL, Gersony D, Nayak H, Weslow RG, Kargman DE, Homma S. Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology. 1996;46(6):1560–6.

    PubMed  Google Scholar 

  37. Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med. 1992;326(4):221–5. doi:10.1056/NEJM199201233260402.

    CAS  PubMed  Google Scholar 

  38. Khatibzadeh M, Mitusch R, Stierle U, Gromoll B, Sheikhzadeh A. Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol. 1996;27(3):664–9.

    CAS  PubMed  Google Scholar 

  39. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med. 1996;334(19):1216–21. doi:10.1056/NEJM199605093341902.

  40. Di Tullio MR, Sacco RL, Homma S. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 1996;335(19):1464; author reply 1464–5. doi:10.1056/NEJM199611073351913.

  41. Mitusch R, Doherty C, Wucherpfennig H, Memmesheimer C, Tepe C, Stierle U, Kessler C, Sheikhzadeh A. Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke. 1997;28(1):36–9.

    CAS  PubMed  Google Scholar 

  42. Davila-Roman VG, Murphy SF, Nickerson NJ, Kouchoukos NT, Schechtman KB, Barzilai B. Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality. J Am Coll Cardiol. 1999;33(5):1308–16.

    CAS  PubMed  Google Scholar 

  43. Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser MG, Amarenco P. Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation. 1997;96(11):3838–41.

    CAS  PubMed  Google Scholar 

  44. Sen S, Oppenheimer SM, Lima J, Cohen B. Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients. Stroke. 2002;33(4):930–5.

    PubMed  Google Scholar 

  45. Montgomery DH, Ververis JJ, McGorisk G, Frohwein S, Martin RP, Taylor WR. Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol. 1996;27(1):95–101. doi:10.1016/0735-1097(95)00431-9.

    CAS  PubMed  Google Scholar 

  46. Pitsavos CE, Aggeli KI, Barbetseas JD, Skoumas IN, Lambrou SG, Frogoudaki AA, Stefanadis CI, Toutouzas PK. Effects of pravastatin on thoracic aortic atherosclerosis in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 1998;82(12):1484–8.

    CAS  PubMed  Google Scholar 

  47. Geraci A, Weinberger J. Natural history of aortic arch atherosclerotic plaque. Neurology. 2000;54(3):749–51.

    CAS  PubMed  Google Scholar 

  48. Sen S, Hinderliter A, Sen PK, Simmons J, Beck J, Offenbacher S, Ohman EM, Oppenheimer SM. Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. Circulation. 2007;116(8):928–35. doi:10.1161/CIRCULATIONAHA.106.671727.

    PubMed  Google Scholar 

  49. Blauth CI, Cosgrove DM, Webb BW, Ratliff NB, Boylan M, Piedmonte MR, Lytle BW, Loop FD. Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc Surg. 1992;103(6):1104–11; discussion 1111–2.

    CAS  PubMed  Google Scholar 

  50. Dubrava J, Garay R. The role of transesophageal echocardiography in detection of cardiogenic and aortic sources of embolism in stroke and transient ischaemic attacks. Vnitr Lek. 2006;52(2):144–51.

    CAS  PubMed  Google Scholar 

  51. Kessler C, Mitusch R, Guo Y, Rosengart A, Sheikhzadeh A. Embolism from the aortic arch in patients with cerebral ischemia. Thromb Res. 1996;84(3):145–55.

    CAS  PubMed  Google Scholar 

  52. Mitusch R, Stierle U, Tepe C, Kummer-Kloess D, Kessler C, Sheikhzadeh A. Systemic embolism in aortic arch atheromatosis. Eur Heart J. 1994;15(10):1373–80.

    CAS  PubMed  Google Scholar 

  53. Faggioli GL, Ferri M, Serra C, Biagini E, Manzoli L, Lodi R, Rapezzi C, Stella A. The residual risk of cerebral embolism after carotid stenting: the complex interplay between stent coverage and aortic arch atherosclerosis. Eur J Vasc Endovasc Surg. 2009;37(5):519–24. doi:10.1016/j.ejvs.2008.12.026.

    CAS  PubMed  Google Scholar 

  54. Guo Y, Jiang X, Chen S, Zhang S, Zhao H, Wu Y. Aortic arch and intra-/extracranial cerebral arterial atherosclerosis in patients suffering acute ischemic strokes. Chin Med J (Engl). 2003;116(12):1840–4.

    Google Scholar 

  55. Tunick PA, Perez JL, Kronzon I. Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med. 1991;115(6):423–7.

    CAS  PubMed  Google Scholar 

  56. Shinokawa N, Hirai T, Takashima S, Kameyama T, Nakagawa K, Asanoi H, Inoue H. A transesophageal echocardiographic study on risk factors for stroke in elderly patients with atrial fibrillation: a comparison with younger patients. Chest. 2001;120(3):840–6.

    CAS  PubMed  Google Scholar 

  57. Reber PU, Patel AG, Stauffer E, Muller MF, Do DD, Kniemeyer HW. Mural aortic thrombi: an important cause of peripheral embolization. J Vasc Surg. 1999;30(6):1084–9.

    CAS  PubMed  Google Scholar 

  58. Harloff A, Simon J, Brendecke S, Assefa D, Helbing T, Frydrychowicz A, Weber J, Olschewski M, Strecker C, Hennig J, Weiller C, Markl M. Complex plaques in the proximal descending aorta: an underestimated embolic source of stroke. Stroke. 2010;41(6):1145–50. doi:10.1161/STROKEAHA.109.577775.

    PubMed  Google Scholar 

  59. Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Petterson TM, O’Fallon WM, Gentile F, Whisnant JP, Wiebers DO, Seward JB. Independent association of high blood pressure and aortic atherosclerosis: a population-based study. Circulation. 2000;102(17):2087–93.

    CAS  PubMed  Google Scholar 

  60. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med. 2005;353(1):46–57. doi:10.1056/NEJMoa043175. 353/1/46 [pii].

    CAS  PubMed  Google Scholar 

  61. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med. 1998;128(8):639–47.

    Google Scholar 

  62. Agmon Y, Khandheria BK, Meissner I, Petterson TM, O’Fallon WM, Wiebers DO, Christianson TJ, McConnell JP, Whisnant JP, Seward JB, Tajik AJ. C-reactive protein and atherosclerosis of the thoracic aorta: a population-based transesophageal echocardiographic study. Arch Intern Med. 2004;164(16):1781–7. doi:10.1001/archinte.164.16.1781.

    PubMed  Google Scholar 

  63. Konecky N, Malinow MR, Tunick PA, Freedberg RS, Rosenzweig BP, Katz ES, Hess DL, Upson B, Leung B, Perez J, Kronzon I. Correlation between plasma homocyst(e)ine and aortic atherosclerosis. Am Heart J. 1997;133(5):534–40.

    CAS  PubMed  Google Scholar 

  64. Tunick PA, Nayar AC, Goodkin GM, Mirchandani S, Francescone S, Rosenzweig BP, Freedberg RS, Katz ES, Applebaum RM, Kronzon I. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002;90(12):1320–5.

    PubMed  Google Scholar 

  65. Tunick PA, Kronzon I. Embolism from the aorta: atheroemboli and thromboemboli. Curr Treat Options Cardiovasc Med. 2001;3(3):181–6.

    PubMed  Google Scholar 

  66. Saric M, Kronzon I. Aortic atherosclerosis and embolic events. Curr Cardiol Rep. 2012;14(3):342–9. doi:10.1007/s11886-012-0261-2.

    PubMed  Google Scholar 

  67. Weinberger J, Azhar S, Danisi F, Hayes R, Goldman M. A new noninvasive technique for imaging atherosclerotic plaque in the aortic arch of stroke patients by transcutaneous real-time B-mode ultrasonography: an initial report. Stroke. 1998;29(3):673–6.

    CAS  PubMed  Google Scholar 

  68. Schwammenthal E, Schwammenthal Y, Tanne D, Tenenbaum A, Garniek A, Motro M, Rabinowitz B, Eldar M, Feinberg MS. Transcutaneous detection of aortic arch atheromas by suprasternal harmonic imaging. J Am Coll Cardiol. 2002;39(7):1127–32.

    PubMed  Google Scholar 

  69. Tamborini G, Galli CA, Maltagliati A, Andreini D, Pontone G, Quaglia C, Ballerini G, Pepi M. Comparison of feasibility and accuracy of transthoracic echocardiography versus computed tomography in patients with known ascending aortic aneurysm. Am J Cardiol. 2006;98(7):966–9. doi:10.1016/j.amjcard.2006.04.043. S0002-9149(06)01191-X [pii].

    PubMed  Google Scholar 

  70. Mirea O, Maffessanti F, Gripari P, Tamborini G, Muratori M, Fusini L, Claudia C, Fiorentini C, Plesea IE, Pepi M. Effects of aging and body size on proximal and ascending aorta and aortic arch: inner edge-to-inner edge reference values in a large adult population by two-dimensional transthoracic echocardiography. J Am Soc Echocardiogr. 2013;26(4):419–27. doi:10.1016/j.echo.2012.12.013. S0894-7317(12)00982-0 [pii].

    PubMed  Google Scholar 

  71. Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke. Circulation. 2006;114(1):63–75. doi:10.1161/CIRCULATIONAHA.105.593418.

    PubMed  Google Scholar 

  72. Katz ES, Konecky N, Tunick PA, Rosenzweig BP, Freedberg RS, Kronzon I. Visualization and identification of the left common carotid and left subclavian arteries: a transesophageal echocardiographic approach. J Am Soc Echocardiogr. 1996;9(1):58–61.

    CAS  PubMed  Google Scholar 

  73. Demopoulos LA, Tunick PA, Bernstein NE, Perez JL, Kronzon I. Protruding atheromas of the aortic arch in symptomatic patients with carotid artery disease. Am Heart J. 1995;129(1):40–4. doi:0002-8703(95)90040-3 [pii].

    CAS  PubMed  Google Scholar 

  74. Nishino M, Masugata H, Yamada Y, Abe H, Hori M, Kamada T. Evaluation of thoracic aortic atherosclerosis by transesophageal echocardiography. Am Heart J. 1994;127(2):336–44.

    CAS  PubMed  Google Scholar 

  75. Vaduganathan P, Ewton A, Nagueh SF, Weilbaecher DG, Safi HJ, Zoghbi WA. Pathologic correlates of aortic plaques, thrombi and mobile “aortic debris” imaged in vivo with transesophageal echocardiography. J Am Coll Cardiol. 1997;30(2):357–63. doi:S0735-1097(97)00181-2 [pii].

    CAS  PubMed  Google Scholar 

  76. Laperche T, Laurian C, Roudaut R, Steg PG. Mobile thromboses of the aortic arch without aortic debris. A transesophageal echocardiographic finding associated with unexplained arterial embolism. The Filiale Echocardiographie de la Societe Francaise de Cardiologie. Circulation. 1997;96(1):288–94.

    CAS  PubMed  Google Scholar 

  77. Tenenbaum A, Garniek A, Shemesh J, Fisman EZ, Stroh CI, Itzchak Y, Vered Z, Motro M. Dual-helical CT for detecting aortic atheromas as a source of stroke: comparison with transesophageal echocardiography. Radiology. 1998;208(1):153–8.

    CAS  PubMed  Google Scholar 

  78. Blanchard DG, Kimura BJ, Dittrich HC, DeMaria AN. Transesophageal echocardiography of the aorta. JAMA. 1994;272(7):546–51.

    CAS  PubMed  Google Scholar 

  79. Zaidat OO, Suarez JI, Hedrick D, Redline S, Schluchter M, Landis DM, Hoit B. Reproducibility of transesophageal echocardiography in evaluating aortic atheroma in stroke patients. Echocardiography. 2005;22(4):326–30. doi:10.1111/j.1540-8175.2005.04044.x.

    PubMed  Google Scholar 

  80. Meissner I, Khandheria BK, Sheps SG, Schwartz GL, Wiebers DO, Whisnant JP, Covalt JL, Petterson TM, Christianson TJ, Agmon Y. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study. J Am Coll Cardiol. 2004;44(5):1018–24. doi:10.1016/j.jacc.2004.05.075.

    PubMed  Google Scholar 

  81. Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S. Aortic arch plaques and risk of recurrent stroke and death. Circulation. 2009;119(17):2376–82. doi:10.1161/CIRCULATIONAHA.108.811935. CIRCULATIONAHA.108.811935 [pii].

    PubMed Central  PubMed  Google Scholar 

  82. Keeley EC, Grines CL. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol. 1998;32(7):1861–5. doi:S0735109798004975 [pii].

    CAS  PubMed  Google Scholar 

  83. van der Linden J, Hadjinikolaou L, Bergman P, Lindblom D. Postoperative stroke in cardiac surgery is related to the location and extent of atherosclerotic disease in the ascending aorta. J Am Coll Cardiol. 2001;38(1):131–5. doi:S0735-1097(01)01328-6 [pii].

    PubMed  Google Scholar 

  84. Osranek M, Pilip A, Patel PR, Molisse T, Tunick PA, Kronzon I. Amounts of aortic atherosclerosis in patients with aortic stenosis as determined by transesophageal echocardiography. Am J Cardiol. 2009;103(5):713–7. doi:10.1016/j.amjcard.2008.11.026. S0002-9149(08)02023-7 [pii].

    PubMed  Google Scholar 

  85. Avegliano G, Evangelista A, Elorz C, Gonzalez-Alujas T, Garcia del Castillo H, Soler-Soler J. Acute peripheral arterial ischemia and suspected aortic dissection: usefulness of transesophageal echocardiography in differential diagnosis with aortic thrombosis. Am J Cardiol. 2002;90(6):674–7. doi:S0002914902025857 [pii].

    PubMed  Google Scholar 

  86. Gottsegen JM, Coplan NL. The atherosclerotic aortic arch: considerations in diagnostic imaging. Prev Cardiol. 2008;11(3):162–7.

    PubMed  Google Scholar 

  87. Wareing TH, Davila-Roman VG, Barzilai B, Murphy SF, Kouchoukos NT. Management of the severely atherosclerotic ascending aorta during cardiac operations. A strategy for detection and treatment. J Thorac Cardiovasc Surg. 1992;103(3):453–62.

    CAS  PubMed  Google Scholar 

  88. Corti R. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy. Pharmacol Ther. 2006;110(1):57–70. doi:10.1016/j.pharmthera.2005.09.004.

    CAS  PubMed  Google Scholar 

  89. Kronzon I. Protruding aortic atheroma: is there a need for a new imaging modality? Isr Med Assoc J. 2000;2(1):54–5.

    CAS  PubMed  Google Scholar 

  90. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48(9):1825–31. doi:10.1016/j.jacc.2006.03.069. S0735-1097(06)01979-6 [pii].

    CAS  PubMed  Google Scholar 

  91. Kumral E, Balkir K, Yagdi T, Kara E, Evyapan D, Bilkay O. Microembolic signals in patients undergoing coronary artery bypass grafting. Effect of aortic atherosclerosis. Tex Heart Inst J. 2001;28(1):16–20.

    CAS  PubMed Central  PubMed  Google Scholar 

  92. Viguier A, Pavy le Traon A, Massabuau P, Valton L, Larrue V. Asymptomatic cerebral embolic signals in patients with acute cerebral ischaemia and severe aortic arch atherosclerosis. J Neurol. 2001;248(9):768–71.

    CAS  PubMed  Google Scholar 

  93. Khatri IA, Mian N, Alkawi A, Janjua N, Kirmani JF, Saric M, Levine JC, Qureshi AI. Catheter-based aortography fails to identify aortic atherosclerotic lesions detected on transesophageal echocardiography. J Neuroimaging. 2005;15(3):261–5. doi:10.1177/1051228405277344.

    PubMed  Google Scholar 

  94. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2006;113(24):e873–923. doi:10.1161/01.STR.0000223048.70103.F1. 113/24/e873 [pii].

    PubMed  Google Scholar 

  95. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Kihara T, Tanaka N, Nakaya K, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI. Eur J Cardiovasc Prev Rehabil. 2009;16(2):222–8. doi:10.1097/HJR.0b013e32832948a0.

    PubMed  Google Scholar 

  96. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation. 2001;104(3):249–52.

    CAS  PubMed  Google Scholar 

  97. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercuri M, Badimon JJ. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years’ follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation. 2002;106(23):2884–7.

    CAS  PubMed  Google Scholar 

  98. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, Muntwyler J, Viles-Gonzalez JF, Weinberger J, Smith DA, Mizsei G, Badimon JJ. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2005;46(1):106–12. doi:10.1016/j.jacc.2005.03.054.

    CAS  PubMed  Google Scholar 

  99. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Higashi K, Kihara T, Sawada S, Iwamoto N, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol. 2005;45(5):733–42. doi:10.1016/j.jacc.2004.11.039. S0735-1097(04)02397-6 [pii].

    CAS  PubMed  Google Scholar 

  100. Smith Jr SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pearson T, Pfeffer MA, Taubert KA. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47(10):2130–9. doi:10.1016/j.jacc.2006.04.026. S0735-1097(06)01043-6 [pii].

    PubMed  Google Scholar 

  101. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey Jr DE, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121(13):e266–369. doi:10.1161/CIR.0b013e3181d4739e. CIR.0b013e3181d4739e [pii].

    PubMed  Google Scholar 

  102. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA. Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: a guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2014. doi:10.1161/STR.0000000000000024.

    Google Scholar 

  103. Stone NJ, Robinson J, Lichtenstein AH, Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith Jr SC, Watson K, Wilson PW. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013. doi:10.1161/01.cir.0000437738.63853.7a. 01.cir.0000437738.63853.7a [pii].

    Google Scholar 

  104. Nakagawa K, Hirai T, Sakurai K, Ohara K, Nozawa T, Inoue H. Thoracic aortic plaque enhances hypercoagulability in patients with nonrheumatic atrial fibrillation. Circ J. 2007;71(1):52–6.

    CAS  PubMed  Google Scholar 

  105. Nakagawa K, Hirai T, Shinokawa N, Takashima S, Nozawa T, Asanoi H, Inoue H. Aortic spontaneous echocardiographic contrast and hemostatic markers in patients with nonrheumatic atrial fibrillation. Chest. 2002;121(2):500–5.

    PubMed  Google Scholar 

  106. Ferrari E, Vidal R, Chevallier T, Baudouy M. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol. 1999;33(5):1317–22.

    CAS  PubMed  Google Scholar 

  107. Bruns FJ, Segel DP, Adler S. Control of cholesterol embolization by discontinuation of anticoagulant therapy. Am J Med Sci. 1978;275(1):105–8.

    CAS  PubMed  Google Scholar 

  108. Blackshear JL, Jahangir A, Oldenburg WA, Safford RE. Digital embolization from plaque-related thrombus in the thoracic aorta: identification with transesophageal echocardiography and resolution with warfarin therapy. Mayo Clin Proc. 1993;68(3):268–72.

    CAS  PubMed  Google Scholar 

  109. Dahlberg PJ, Frecentese DF, Cogbill TH. Cholesterol embolism: experience with 22 histologically proven cases. Surgery. 1989;105(6):737–46. doi:0039-6060(89)90333-4 [pii].

    CAS  PubMed  Google Scholar 

  110. Hausmann D, Gulba D, Bargheer K, Niedermeyer J, Comess KA, Daniel WG. Successful thrombolysis of an aortic-arch thrombus in a patient after mesenteric embolism. N Engl J Med. 1992;327(7):500–1. doi:10.1056/NEJM199208133270717.

    CAS  PubMed  Google Scholar 

  111. Blackshear JL, Zabalgoitia M, Pennock G, Fenster P, Strauss R, Halperin J, Asinger R, Pearce LA. Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography. Am J Cardiol. 1999;83(3):453–455, A459. doi:S0002914998008868 [pii].

    CAS  PubMed  Google Scholar 

  112. Trial C. Aortic Arch Related Cerebral Hazard Trial (ARCH). 2005.

    Google Scholar 

  113. Tsilimparis N, Hanack U, Pisimisis G, Yousefi S, Wintzer C, Ruckert RI. Thrombus in the non-aneurysmal, non-atherosclerotic descending thoracic aorta – an unusual source of arterial embolism. Eur J Vasc Endovasc Surg. 2011;41(4):450–7. doi:10.1016/j.ejvs.2010.11.004. S1078-5884(10)00681-7 [pii].

    CAS  PubMed  Google Scholar 

  114. Pagni S, Trivedi J, Ganzel BL, Williams M, Kapoor N, Ross C, Slater AD. Thoracic aortic mobile thrombus: is there a role for early surgical intervention? Ann Thorac Surg. 2011;91(6):1875–81. doi:10.1016/j.athoracsur.2011.02.011. S0003-4975(11)00435-8 [pii].

    PubMed  Google Scholar 

  115. Martens T, Van Herzeele I, Jacobs B, De Ryck F, Randon C, Vermassen F. Treatment of symptomatic mobile aortic thrombus. Acta Chir Belg. 2010;110(3):361–4.

    CAS  PubMed  Google Scholar 

  116. Soleimani A, Marzban M, Sahebjam M, Shirani S, Sotoudeh-Anvari M, Abbasi A. Floating thrombus in the aortic arch as an origin of simultaneous peripheral emboli. J Card Surg. 2008;23(6):762–4. doi:10.1111/j.1540-8191.2008.00694.x. JCS694 [pii].

    PubMed  Google Scholar 

  117. Berneder S, van Ingen G, Eigel P. Arch thrombus formation in an apparently normal aorta as a source for recurrent peripheral embolization. Thorac Cardiovasc Surg. 2006;54(8):548–9. doi:10.1055/s-2006-923976.

    CAS  PubMed  Google Scholar 

  118. Taglietti L, Pontoglio S, Di Flumeri G, EP R, Vettoretto N, Ghilardi G, Barozzi G, Poiatti R, Giovanetti M. Acute thrombosis of abdominal aorta and hypercoagulable disorders. Int Angiol. 2008;27(2):157–65.

    CAS  PubMed  Google Scholar 

  119. Marcu CB, Donohue TJ, Ghantous AE. Spontaneous aortic thrombosis and embolization: antithrombin deficiency and the work-up of hypercoagulable states. CMAJ. 2005;173(9):1027–9. doi:10.1503/cmaj.050464. 173/9/1027 [pii].

    PubMed Central  PubMed  Google Scholar 

  120. Kotani S, Hattori K, Kato Y, Shibata T. Thrombus in the distal aortic arch after apicoaortic conduit for severe aortic stenosis. Interact Cardiovasc Thorac Surg. 2010;10(3):486–8. doi:10.1510/icvts.2009.220707. icvts.2009.220707 [pii].

    PubMed  Google Scholar 

  121. Chin SO, Lee JJ, Hwang YH, Han JJ, Maeng CH, Baek SK, Choi CW. Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer. Int J Hematol. 2010;91(5):892–6. doi:10.1007/s12185-010-0571-3.

    PubMed  Google Scholar 

  122. Stordiau GE, Alecha JS, Goni S, Zozaya JM, Centeno R, Tricas JM. Arterial thromboembolism from aortic floating thrombus in a patient with Crohn’s disease. J Crohns Colitis. 2011;5(2):169–70. doi:10.1016/j.crohns.2011.01.002. S1873-9946(11)00033-X [pii].

    PubMed  Google Scholar 

  123. Sanon S, Phung MK, Lentz R, Buja LM, Tung PP, McPherson DD, Fuentes F. Floating, non-occlusive, mobile aortic thrombus and splenic infarction associated with protein C deficiency. J Am Soc Echocardiogr. 2009;22(12):1419.e1411–3. doi:10.1016/j.echo.2009.06.004. S0894-7317(09)00575-6 [pii].

    Google Scholar 

  124. Sohn V, Arthurs Z, Andersen C, Starnes B. Aortic thrombus due to essential thrombocytosis: strategies for medical and surgical management. Ann Vasc Surg. 2008;22(5):676–80. doi:10.1016/j.avsg.2007.12.018. S0890-5096(08)00079-4 [pii].

    PubMed  Google Scholar 

  125. Loffroy R, Boussel L, Farhat F, Douek P. Isolated floating thrombus of the thoracic aorta: a rare sign of traumatic aortic injury managed with anticoagulant therapy. Ann Thorac Surg. 2007;84(5):1766. doi:10.1016/j.athoracsur.2006.10.078. S0003-4975(06)02117-5 [pii].

    PubMed  Google Scholar 

  126. Chatterjee S, Eagle SS, Adler DH, Byrne JG. Incidental discovery of an ascending aortic thrombus: should this patient undergo surgical intervention? J Thorac Cardiovasc Surg. 2010;140(1):e14–6. doi:10.1016/j.jtcvs.2009.07.010. S0022-5223(09)00915-5 [pii].

    PubMed  Google Scholar 

  127. Fanelli F, Gazzetti M, Boatta E, Ruggiero M, Lucatelli P, Speziale F. Acute left arm ischemia associated with floating thrombus in the proximal descending aorta: combined endovascular and surgical therapy. Cardiovasc Intervent Radiol. 2011;34(1):193–7. doi:10.1007/s00270-010-9804-3.

    CAS  PubMed  Google Scholar 

  128. Hisagi M, Morota T, Endo M, Taketani T, Takamoto S. Floating thrombus in the ascending aorta. Gen Thorac Cardiovasc Surg. 2007;55(1):38–40.

    PubMed  Google Scholar 

  129. Boufi M, Mameli A, Compes P, Hartung O, Alimi YS. Elective stent-graft treatment for the management of thoracic aorta mural thrombus. Eur J Vasc Endovasc Surg. 2014;47(4):335–41. doi:10.1016/j.ejvs.2013.11.014. S1078-5884(13)00733-8 [pii].

    CAS  PubMed  Google Scholar 

  130. Luebke T, Aleksic M, Brunkwall J. Endovascular therapy of a symptomatic mobile thrombus of the thoracic aorta. Eur J Vasc Endovasc Surg. 2008;36(5):550–2. doi:10.1016/j.ejvs.2008.07.004. S1078-5884(08)00398-5 [pii].

    CAS  PubMed  Google Scholar 

  131. Scott DJ, White JM, Arthurs ZM. Endovascular management of a mobile thoracic aortic thrombus following recurrent distal thromboembolism: a case report and literature review. Vasc Endovascular Surg. 2014;48(3):246–50. doi:10.1177/1538574413513845. 1538574413513845 [pii].

    PubMed  Google Scholar 

  132. Mahnken AH, Hoffman A, Autschbach R, Damberg AL. Bare metal stenting for endovascular exclusion of aortic arch thrombi. Cardiovasc Intervent Radiol. 2013;36(4):1127–31. doi:10.1007/s00270-013-0566-6.

    PubMed  Google Scholar 

  133. Metsemakers WJ, Duchateau J, Vanhoenacker F, Tielemans Y, De Leersnyder J. Floating aortic thrombus: the endovascular approach. Acta Chir Belg. 2013;113(1):47–50.

    PubMed  Google Scholar 

  134. Wolf PS, Burman HE, Starnes BW. Endovascular treatment of massive thoracic aortic thrombus and associated ruptured atheroma. Ann Vasc Surg. 2010;24(3):416.e9–416.e12. doi:10.1016/j.avsg.2009.10.004.

    Google Scholar 

  135. Alhan C, Karabulut H, Senay S, Cagil H, Toraman F. Endovascular treatment of occlusive abdominal aortic thrombosis. Heart Vessels. 2010;25(1):70–2. doi:10.1007/s00380-009-1169-7.

    PubMed  Google Scholar 

  136. Piffaretti G, Tozzi M, Caronno R, Castelli P. Endovascular treatment for mobile thrombus of the thoracic aorta. Eur J Cardiothorac Surg. 2007;32(4):664–6. doi:10.1016/j.ejcts.2007.06.043. S1010-7940(07)00607-0 [pii].

    PubMed  Google Scholar 

  137. Fueglistaler P, Wolff T, Guerke L, Stierli P, Eugster T. Endovascular stent graft for symptomatic mobile thrombus of the thoracic aorta. J Vasc Surg. 2005;42(4):781–3. doi:10.1016/j.jvs.2005.05.054. S0741-5214(05)00974-2 [pii].

    PubMed  Google Scholar 

  138. Nakajima M, Tsuchiya K, Honda Y, Koshiyama H, Kobayashi T. Acute pulmonary embolism after cerebral infarction associated with a mobile thrombus in the ascending aorta. Gen Thorac Cardiovasc Surg. 2009;57(12):654–6. doi:10.1007/s11748-009-0444-y.

    PubMed  Google Scholar 

  139. Bockler D, von Tengg-Kobligk H, Schoebinger M, Gross ML, Schumacher H, Ockert S, Allenberg JR. An unusual cause of peripheral artery embolism: floating thrombus of the thoracic aorta surgically removed. Vasa. 2007;36(2):121–3.

    CAS  PubMed  Google Scholar 

  140. Krishnamoorthy V, Bhatt K, Nicolau R, Borhani M, Schwartz DE. Transesophageal echocardiography-guided aortic thrombectomy in a patient with a mobile thoracic aortic thrombus. Semin Cardiothorac Vasc Anesth. 2011;15(4):176–8. doi:10.1177/1089253211415123. 1089253211415123 [pii].

    PubMed  Google Scholar 

  141. Josephson GD, Tiefenbrun J, Harvey J. Thrombosis of the descending thoracic aorta: a case report. Surgery. 1993;114(3):598–600. doi:0039-6060(93)90300-3 [pii].

    CAS  PubMed  Google Scholar 

  142. Kalangos A, Baldovinos A, Vuille C, Montessuit M, Faidutti B. Floating thrombus in the ascending aorta: a rare cause of peripheral emboli. J Vasc Surg. 1997;26(1):150–4. doi:S0741-5214(97)70161-7 [pii].

    CAS  PubMed  Google Scholar 

  143. Sawada T, Shimokawa T. Giant thrombus in the ascending aorta that caused systemic embolism. Interact Cardiovasc Thorac Surg. 2011;12(6):1048–50. doi:10.1510/icvts.2011.266445. icvts.2011.266445 [pii].

    PubMed  Google Scholar 

  144. Calderon P, Heredero A, Pastor A, Higueras J, Hernandez J, Karagounis PA, Aldamiz-Echevarria G. Successful removal of a floating thrombus in ascending aorta. Ann Thorac Surg. 2011;91(5):e67–9. doi:10.1016/j.athoracsur.2010.12.011. S0003-4975(10)02788-8 [pii].

    PubMed  Google Scholar 

  145. Namura O, Sogawa M, Asami F, Okamoto T, Hanzawa K, Hayashi J. Floating thrombus originating from an almost normal thoracic aorta. Gen Thorac Cardiovasc Surg. 2011;59(9):612–5. doi:10.1007/s11748-010-0752-2.

    PubMed  Google Scholar 

  146. Tunick PA, Culliford AT, Lamparello PJ, Kronzon I. Atheromatosis of the aortic arch as an occult source of multiple systemic emboli. Ann Intern Med. 1991;114(5):391–2.

    CAS  PubMed  Google Scholar 

  147. Iyer AP, Sadasivan D, Kamal U, Sharma S. Resolution of large intra-aortic thrombus following anticoagulation therapy. Heart Lung Circ. 2009;18(1):49–50. doi:10.1016/j.hlc.2007.09.006. S1443-9506(07)00900-6 [pii].

    PubMed  Google Scholar 

  148. Pousios D, Velissaris T, Duggan S, Tsang G. Floating intra-aortic thrombus presenting as distal arterial embolism. Interact Cardiovasc Thorac Surg. 2009;9(3):532–4. doi:10.1510/icvts.2009.206268. icvts.2009.206268 [pii].

    PubMed  Google Scholar 

  149. Fayad ZY, Semaan E, Fahoum B, Briggs M, Tortolani A, D’Ayala M. Aortic mural thrombus in the normal or minimally atherosclerotic aorta. Ann Vasc Surg. 2013;27(3):282–90. doi:10.1016/j.avsg.2012.03.011. S0890-5096(12)00258-0 [pii].

    PubMed  Google Scholar 

  150. Kruger T, Liske B, Ziemer S, Lindemann S, Ziemer G. Thrombolysis to treat thrombi of the aortic arch. Clin Appl Thromb Hemost. 2011;17(4):340–5. doi:10.1177/1076029610364519. 1076029610364519 [pii].

    PubMed  Google Scholar 

  151. Durdil V, Fiedler J, Alan D, Vejvoda J, Veselka J. Multiple mobile aortic thrombosis treated by thrombolysis. A case report. J Thromb Thrombolysis. 2007;24(3):315–6. doi:10.1007/s11239-007-0091-z.

    PubMed  Google Scholar 

  152. Bays HE, Dujovne CA. Drug interactions of lipid-altering drugs. Drug Saf. 1998;19(5):355–71.

    CAS  PubMed  Google Scholar 

  153. Farmer JA, Gotto Jr AM. Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug Saf. 1994;11(5):301–9.

    CAS  PubMed  Google Scholar 

  154. Pan HY, DeVault AR, Swites BJ, Whigan D, Ivashkiv E, Willard DA, Brescia D. Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia. Clin Pharmacol Ther. 1990;48(2):201–7. doi:0009-9236(90)90152-U [pii].

    CAS  PubMed  Google Scholar 

  155. Nakai A, Nishikata M, Matsuyama K, Ichikawa M. Drug interaction between simvastatin and cholestyramine in vitro and in vivo. Biol Pharm Bull. 1996;19(9):1231–3.

    CAS  PubMed  Google Scholar 

  156. Smith HT, Jokubaitis LA, Troendle AJ, Hwang DS, Robinson WT. Pharmacokinetics of fluvastatin and specific drug interactions. Am J Hypertens. 1993;6(11 Pt 2):375S–82. doi:0895-7061(93)90482-2 [pii].

    CAS  PubMed  Google Scholar 

  157. Richter WO, Jacob BG, Schwandt P. Interaction between fibre and lovastatin. Lancet. 1991;338(8768):706.

    CAS  PubMed  Google Scholar 

  158. Martin PD, Schneck DW, Dane AL, Warwick MJ. The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics. Curr Med Res Opin. 2008;24(4):1231–5. doi:10.1185/030079908X280662. 4355 [pii].

    CAS  PubMed  Google Scholar 

  159. Langtry HD, Markham A. Fluvastatin: a review of its use in lipid disorders. Drugs. 1999;57(4):583–606.

    CAS  PubMed  Google Scholar 

  160. Plosker GL, Wagstaff AJ. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia. Drugs. 1996;51(3):433–59.

    CAS  PubMed  Google Scholar 

  161. Pan HY, DeVault AR, Brescia D, Willard DA, McGovern ME, Whigan DB, Ivashkiv E. Effect of food on pravastatin pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther Toxicol. 1993;31(6):291–4.

    CAS  PubMed  Google Scholar 

  162. Deslypere JP. Clinical implications of the biopharmaceutical properties of fluvastatin. Am J Cardiol. 1994;73(14):12D–7.

    CAS  PubMed  Google Scholar 

  163. Radulovic LL, Cilla DD, Posvar EL, Sedman AJ, Whitfield LR. Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor. J Clin Pharmacol. 1995;35(10):990–4.

    CAS  PubMed  Google Scholar 

  164. Lennernas H, Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet. 1997;32(5):403–25. doi:10.2165/00003088-199732050-00005.

    CAS  PubMed  Google Scholar 

  165. Izzo AA, Di Carlo G, Borrelli F, Ernst E. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol. 2005;98(1):1–14. doi:10.1016/j.ijcard.2003.06.039. S0167527303006272 [pii].

    PubMed  Google Scholar 

  166. Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet. 2002;41(5):343–70. doi:10.2165/00003088-200241050-00003.

    CAS  PubMed  Google Scholar 

  167. Kim J, Ahn BJ, Chae HS, Han S, Doh K, Choi J, Jun YK, Lee YW, Yim DS. A population pharmacokinetic-pharmacodynamic model for simvastatin that predicts low-density lipoprotein-cholesterol reduction in patients with primary hyperlipidaemia. Basic Clin Pharmacol Toxicol. 2011;109(3):156–63. doi:10.1111/j.1742-7843.2011.00700.x.

    CAS  PubMed  Google Scholar 

  168. Wenaweser P, Eshtehardi P, Abrecht L, Zwahlen M, Schmidlin K, Windecker S, Meier B, Haeberli A, Hess OM. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial. Thromb Haemost. 2010;104(3):554–62. doi:10.1160/TH09-11-0765. 09-11-0765 [pii].

    CAS  PubMed  Google Scholar 

  169. Geisler T, Zurn C, Paterok M, Gohring-Frischholz K, Bigalke B, Stellos K, Seizer P, Kraemer BF, Dippon J, May AE, Herdeg C, Gawaz M. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy. Eur Heart J. 2008;29(13):1635–43. doi:10.1093/eurheartj/ehn212. ehn212 [pii].

    CAS  PubMed  Google Scholar 

  170. Dinicolantonio JJ, Serebruany VL. Exploring the ticagrelor-statin interplay in the PLATO trial. Cardiology. 2013;124(2):105–7. doi:10.1159/000346151.

    CAS  PubMed  Google Scholar 

  171. Teng R, Mitchell PD, Butler KA. Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers. Eur J Clin Pharmacol. 2013;69(3):477–87. doi:10.1007/s00228-012-1369-4.

    CAS  PubMed  Google Scholar 

  172. Neuvonen PJ, Kantola T, Kivisto KT. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. Clin Pharmacol Ther. 1998;63(3):332–41. doi:10.1016/S0009-9236(98)90165-5.

    CAS  PubMed  Google Scholar 

  173. Horn M. Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals. Arch Dermatol. 1996;132(10):1254.

    CAS  PubMed  Google Scholar 

  174. Goldberg R, Roth D. Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine. Transplantation. 1996;62(11):1559–64.

    CAS  PubMed  Google Scholar 

  175. McKenney JM. Efficacy and safety of rosuvastatin in treatment of dyslipidemia. Am J Health Syst Pharm. 2005;62(10):1033–47.

    CAS  PubMed  Google Scholar 

  176. Athyros VG, Mikhailidis DP, Papageorgiou AA, Bouloukos VI, Pehlivanidis AN, Symeonidis AN, Kakafika AI, Daskalopoulou SS, Elisaf M. Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study. Platelets. 2005;16(2):65–71. doi:10.1080/09537100400009321. VG477N1368450605 [pii].

    CAS  PubMed  Google Scholar 

  177. Angiolillo DJ, Alfonso F. Clopidogrel-statin interaction: myth or reality? J Am Coll Cardiol. 2007;50(4):296–8. doi:10.1016/j.jacc.2007.04.041. S0735-1097(07)01471-4 [pii].

    CAS  PubMed  Google Scholar 

  178. Steinhubl SR, Akers WS. Clopidogrel-statin interaction: a mountain or a mole hill? Am Heart J. 2006;152(2):200–3. doi:10.1016/j.ahj.2006.01.001. S0002-8703(06)00051-2 [pii].

    CAS  PubMed  Google Scholar 

  179. Tafreshi MJ, Zagnoni LG, Gentry EJ. Combination of clopidogrel and statins: a hypothetical interaction or therapeutic dilemma? Pharmacotherapy. 2006;26(3):388–94. doi:10.1592/phco.26.3.388.

    CAS  PubMed  Google Scholar 

  180. Blagojevic A, Delaney JA, Levesque LE, Dendukuri N, Boivin JF, Brophy JM. Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study. Pharmacoepidemiol Drug Saf. 2009;18(5):362–9. doi:10.1002/pds.1716.

    CAS  PubMed  Google Scholar 

  181. Shen J, Zhang RY, Zhang Q. Impact of statins on clopidogrel platelet inhibition in patients with acute coronary syndrome or stable angina. Zhonghua Xin Xue Guan Bing Za Zhi. 2008;36(9):807–11.

    CAS  PubMed  Google Scholar 

  182. Bhindi R, Ormerod O, Newton J, Banning AP, Testa L. Interaction between statins and clopidogrel: is there anything clinically relevant? QJM. 2008;101(12):915–25. doi:10.1093/qjmed/hcn089. hcn089 [pii].

    CAS  PubMed  Google Scholar 

  183. Zurn CS, Geisler T, Paterok M, Gawaz M. Influence of statins on the antiplatelet effect of clopidogrel and on cardiovascular outcome in patients after coronary intervention. Dtsch Med Wochenschr. 2008;133(16):817–22. doi:10.1055/s-2008-1075654.

    CAS  PubMed  Google Scholar 

  184. Trenk D, Hochholzer W, Frundi D, Stratz C, Valina CM, Bestehorn HP, Buttner HJ, Neumann FJ. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement. Thromb Haemost. 2008;99(1):174–81. doi:10.1160/TH07-08-0503. 08010174 [pii].

    CAS  PubMed  Google Scholar 

  185. Han YL, Li CY, Li Y, Kang J, Yan CH. The antiplatelet effect of clopidogrel is not attenuated by statin treatment in patients with acute coronary syndromes undergone coronary stenting. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35(9):788–92.

    CAS  PubMed  Google Scholar 

  186. Saw J, Brennan DM, Steinhubl SR, Bhatt DL, Mak KH, Fox K, Topol EJ. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. J Am Coll Cardiol. 2007;50(4):291–5. doi:10.1016/j.jacc.2007.01.097. S0735-1097(07)01474-X [pii].

    CAS  PubMed  Google Scholar 

  187. Serebruany VL, Midei MG, Malinin AI, Oshrine BR, Lowry DR, Sane DC, Tanguay JF, Steinhubl SR, Berger PB, O’Connor CM, Hennekens CH. Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study. Arch Intern Med. 2004;164(18):2051–7. doi:10.1001/archinte.164.18.2051. 164/18/2051 [pii].

    CAS  PubMed  Google Scholar 

  188. Wienbergen H, Gitt AK, Schiele R, Juenger C, Heer T, Meisenzahl C, Limbourg P, Bossaller C, Senges J. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. Am J Cardiol. 2003;92(3):285–8. doi:S000291490300626X [pii].

    CAS  PubMed  Google Scholar 

  189. Serebruany VL, Malinin AI, Callahan KP, Gurbel PA, Steinhubl SR. Statins do not affect platelet inhibition with clopidogrel during coronary stenting. Atherosclerosis. 2001;159(1):239–41. doi:S0021915001006062 [pii].

    CAS  PubMed  Google Scholar 

  190. Wenaweser P, Windecker S, Billinger M, Cook S, Togni M, Meier B, Haeberli A, Hess OM. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis. Am J Cardiol. 2007;99(3):353–6. doi:10.1016/j.amjcard.2006.08.036. S0002-9149(06)02061-3 [pii].

    CAS  PubMed  Google Scholar 

  191. Gulec S, Ozdol C, Rahimov U, Atmaca Y, Kumbasar D, Erol C. Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction. J Invasive Cardiol. 2005;17(11):589–93.

    PubMed  Google Scholar 

  192. Neubauer H, Gunesdogan B, Hanefeld C, Spiecker M, Mugge A. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function – a flow cytometry study. Eur Heart J. 2003;24(19):1744–9. doi:S0195668X03004421 [pii].

    CAS  PubMed  Google Scholar 

  193. Mukherjee D, Kline-Rogers E, Fang J, Munir K, Eagle KA. Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome. Heart. 2005;91(1):23–6. doi:10.1136/hrt.2004.035014. 91/1/23 [pii].

    CAS  PubMed Central  PubMed  Google Scholar 

  194. Mach F, Senouf D, Fontana P, Boehlen F, Reber G, Daali Y, de Moerloose P, Sigwart U. Not all statins interfere with clopidogrel during antiplatelet therapy. Eur J Clin Invest. 2005;35(8):476–81. doi:10.1111/j.1365-2362.2005.01522.x. ECI1522 [pii].

    CAS  PubMed  Google Scholar 

  195. Smith SM, Judge HM, Peters G, Storey RF. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention. Platelets. 2004;15(8):465–74. doi:10.1080/0953710412331272532. YR2F8RXTTGNJNND1 [pii].

    CAS  PubMed  Google Scholar 

  196. Ojeifo O, Wiviott SD, Antman EM, Murphy SA, Udell JA, Bates ER, Mega JL, Sabatine MS, O’Donoghue ML. Concomitant administration of clopidogrel with statins or calcium channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38) trial. J Am Coll Cardiol Intv. 2013. doi:10.1016/j.jcin.2013.06.014.

    Google Scholar 

  197. Farid NA, Small DS, Payne CD, Jakubowski JA, Brandt JT, Li YG, Ernest CS, Salazar DE, Konkoy CS, Winters KJ. Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects. Pharmacotherapy. 2008;28(12):1483–94. doi:10.1592/phco.28.12.1483.

    CAS  PubMed  Google Scholar 

  198. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165(10):1095–106. doi:10.1001/archinte.165.10.1095.

    CAS  PubMed  Google Scholar 

  199. Nutescu E, Chuatrisorn I, Hellenbart E. Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. J Thromb Thrombolysis. 2011;31(3):326–43. doi:10.1007/s11239-011-0561-1.

    CAS  PubMed  Google Scholar 

  200. Black DJ, Kunze KL, Wienkers LC, Gidal BE, Seaton TL, McDonnell ND, Evans JS, Bauwens JE, Trager WF. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies. Drug Metab Dispos. 1996;24(4):422–8.

    CAS  PubMed  Google Scholar 

  201. Hemeryck A, De Vriendt C, Belpaire FM. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes. Eur J Clin Pharmacol. 1999;54(12):947–51.

    CAS  PubMed  Google Scholar 

  202. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777–98. doi:10.2165/11317010-000000000-00000.

    CAS  PubMed  Google Scholar 

  203. Westergren T, Johansson P, Molden E. Probable warfarin-simvastatin interaction. Ann Pharmacother. 2007;41(7):1292–5. doi:10.1345/aph.1K167.

    CAS  PubMed  Google Scholar 

  204. Tadros R, Shakib S. Warfarin – indications, risks and drug interactions. Aust Fam Physician. 2010;39(7):476–9.

    PubMed  Google Scholar 

  205. Ghaswalla PK, Harpe SE, Tassone D, Slattum PW. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic. Am J Geriatr Pharmacother. 2012;10(6):352–60. doi:10.1016/j.amjopharm.2012.09.006.

    CAS  PubMed  Google Scholar 

  206. Rice PJ, Perry RJ, Afzal Z, Stockley IH. Antibacterial prescribing and warfarin: a review. Br Dent J. 2003;194(8):411–5. doi:10.1038/sj.bdj.4810049.

    CAS  PubMed  Google Scholar 

  207. Abernethy DR, Kaminsky LS, Dickinson TH. Selective inhibition of warfarin metabolism by diltiazem in humans. J Pharmacol Exp Ther. 1991;257(1):411–5.

    CAS  PubMed  Google Scholar 

  208. Yamazaki H, Shimada T. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin. Drug Metab Dispos. 1998;26(11):1053–7.

    CAS  PubMed  Google Scholar 

  209. Randinitis EJ, Alvey CW, Koup JR, Rausch G, Abel R, Bron NJ, Hounslow NJ, Vassos AB, Sedman AJ. Drug interactions with clinafloxacin. Antimicrob Agents Chemother. 2001;45(9):2543–52.

    CAS  PubMed Central  PubMed  Google Scholar 

  210. Heimark LD, Wienkers L, Kunze K, Gibaldi M, Eddy AC, Trager WF, O’Reilly RA, Goulart DA. The mechanism of the interaction between amiodarone and warfarin in humans. Clin Pharmacol Ther. 1992;51(4):398–407.

    CAS  PubMed  Google Scholar 

  211. O’Reilly RA, Trager WF, Rettie AE, Goulart DA. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans. Clin Pharmacol Ther. 1987;42(3):290–4. doi:0009-9236(87)90150-0 [pii].

    PubMed  Google Scholar 

  212. Rettie AE, Jones JP. Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics. Annu Rev Pharmacol Toxicol. 2005;45:477–94. doi:10.1146/annurev.pharmtox.45.120403.095821.

    CAS  PubMed  Google Scholar 

  213. Van Booven D, Marsh S, McLeod H, Carrillo MW, Sangkuhl K, Klein TE, Altman RB. Cytochrome P450 2C9-CYP2C9. Pharmacogenet Genomics. 2010;20(4):277–81. doi:10.1097/FPC.0b013e3283349e84.

    PubMed Central  PubMed  Google Scholar 

  214. Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA. Applications of CYP450 testing in the clinical setting. Mol Diagn Ther. 2013;17(3):165–84. doi:10.1007/s40291-013-0028-5.

    CAS  PubMed Central  PubMed  Google Scholar 

  215. Nathisuwan S, Dilokthornsakul P, Chaiyakunapruk N, Morarai T, Yodting T, Piriyachananusorn N. Assessing evidence of interaction between smoking and warfarin: a systematic review and meta-analysis. Chest. 2011;139(5):1130–9. doi:10.1378/chest.10-0777. 139/5/1130 [pii].

    PubMed  Google Scholar 

  216. Hersh EV, Moore PA. Drug interactions in dentistry: the importance of knowing your CYPs. J Am Dent Assoc. 2004;135(3):298–311.

    CAS  PubMed  Google Scholar 

  217. Hijazi Y, Boulieu R. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos. 2002;30(7):853–8.

    CAS  PubMed  Google Scholar 

  218. Kimura Y, Ito H, Ohnishi R, Hatano T. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem Toxicol. 2010;48(1):429–35. doi:10.1016/j.fct.2009.10.041. S0278-6915(09)00502-X [pii].

    CAS  PubMed  Google Scholar 

  219. Miners JO, Birkett DJ. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol. 1998;45(6):525–38.

    CAS  PubMed Central  PubMed  Google Scholar 

  220. Si D, Wang Y, Zhou YH, Guo Y, Wang J, Zhou H, Li ZS, Fawcett JP. Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab Dispos. 2009;37(3):629–34. doi:10.1124/dmd.108.023416. dmd.108.023416 [pii].

    CAS  PubMed  Google Scholar 

  221. He N, Zhang WQ, Shockley D, Edeki T. Inhibitory effects of H1-antihistamines on CYP2D6- and CYP2C9-mediated drug metabolic reactions in human liver microsomes. Eur J Clin Pharmacol. 2002;57(12):847–51.

    CAS  PubMed  Google Scholar 

  222. Zhou SF, Xue CC, Yu XQ, Li C, Wang G. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit. 2007;29(6):687–710. doi:10.1097/FTD.0b013e31815c16f5.

    CAS  PubMed  Google Scholar 

  223. Feierman DE, Melinkov Z, Nanji AA. Induction of CYP3A by ethanol in multiple in vitro and in vivo models. Alcohol Clin Exp Res. 2003;27(6):981–8. doi:10.1097/01.ALC.0000071738.53337.F4.

    CAS  PubMed  Google Scholar 

  224. Kumagai T, Suzuki H, Sasaki T, Sakaguchi S, Miyairi S, Yamazoe Y, Nagata K. Polycyclic aromatic hydrocarbons activate CYP3A4 gene transcription through human pregnane X receptor. Drug Metab Pharmacokinet. 2012;27(2):200–6.

    CAS  PubMed  Google Scholar 

  225. Medina-Diaz IM, Arteaga-Illan G, de Leon MB, Cisneros B, Sierra-Santoyo A, Vega L, Gonzalez FJ, Elizondo G. Pregnane X receptor-dependent induction of the CYP3A4 gene by o, p′-1,1,1,-trichloro-2,2-bis (p-chlorophenyl)ethane. Drug Metab Dispos. 2007;35(1):95–102. doi:10.1124/dmd.106.011759.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Cardiologico Monzino, IRCCS, Milan, Italy

    Damiano Baldassarre & Mauro Pepi

  2. Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy

    Damiano Baldassarre

Authors
  1. Damiano Baldassarre
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mauro Pepi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mauro Pepi .

Editor information

Editors and Affiliations

  1. Imaging Cardiac Department Aortic Diseases Unit, Vall d’hebrón University Hospital, Barcelona, Spain

    Arturo Evangelista

  2. Heart Center Rostock, Rostock School of Medicine University Hospital Rostock, Rostock, Germany

    Christoph A. Nienaber

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Baldassarre, D., Pepi, M. (2015). Aortic Atherosclerosis as an Embolic Source. In: Evangelista, A., Nienaber, C. (eds) Pharmacotherapy in Aortic Disease. Current Cardiovascular Therapy, vol 7. Springer, Cham. https://doi.org/10.1007/978-3-319-09555-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09555-4_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09554-7

  • Online ISBN: 978-3-319-09555-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation